Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 82
Filter
Add more filters










Publication year range
1.
Curr Res Toxicol ; 3: 100081, 2022.
Article in English | MEDLINE | ID: mdl-35814289

ABSTRACT

Pregnant mothers continue smoking and drinking during pregnancy. To clarify the mechanisms of nicotine and ethanol toxicity during development, we have examined their effects on endoplasmic reticulum (ER) stress in human first trimester and term placental explants. First trimester and term human placental explants were treated with ethanol (2 ‰) or nicotine (15 µM), or their combination. The ER stress markers glucose regulated protein 78 (GRP78/BiP) and inositol requiring enzyme 1 α (IRE1α) were analyzed by immunoblotting. A statistically significant increase (p < 0.05) of GRP78/BiP by nicotine was noted in first trimester placental explants at 48 h, and in term placental explants at 24 h. Ethanol did not change protein expression of GRP78/BiP in either first trimester or term placental explants. IRE1α increased, although not statistically significantly, by all treatments in both first trimester and term placental explants. Thus, regardless of the known structural and functional differences in early and late placenta, both responded very similarly to the toxic compounds studied. These data support our earlier results in BeWo cells (Repo et al., 2014) implicating that nicotine induces ER stress in human placenta and may interfere with placental functions potentially disrupting fetal growth and development.

2.
Tissue Cell ; 73: 101662, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34628212

ABSTRACT

Bisphenol A (BPA) is an endocrine disruptor extensively used in the production of polycarbonate plastics and epoxy resins and a component of liquid and food containers. It is a hazard in the prenatal period because of its presence in the placenta, fetal membranes, amniotic fluid, maternal and fetal blood and its ability to cross the placenta and reach the fetus. Estimation of the risk of BPA exposure during in utero life is extremely important in order to prevent complications of pregnancy and fetal growth. This review describes in vitro models of the human materno-fetal interface. It also outlines the effects of BPA at doses indicated as "physiological", namely at the concentrations found in the general population, and at "supraphysiological" and "subphysiological" doses, i.e. above and below the physiological range. This work will help clarify the discrepancies observed in studies on the effects of BPA on human reproduction and pregnancy, and it will be useful for the choice of appropriate in vitro models for future studies aimed at identifying the potential impact of BPA on specific functional processes.


Subject(s)
Benzhydryl Compounds/toxicity , Maternal-Fetal Exchange/drug effects , Organ Specificity , Phenols/toxicity , Female , Humans , Models, Biological , Organ Specificity/drug effects , Pregnancy , Risk Factors
3.
Placenta ; 60: 93-99, 2017 Dec.
Article in English | MEDLINE | ID: mdl-29208246

ABSTRACT

By the 1890s, placental arrangements had been documented macroscopically in lizards and fishes, but placental studies on such species lagged far behind research on mammals. In 1891, the biologist Ercole Giacomini (at the University of Siena, Italy) published the first histological analysis of a reptile placenta. Focusing on a placentotrophic lizard (Chalcides chalcides) with a morphologically complex placenta, Giacomini documented the histological and cellular bases for placental nutrient transfer and gas exchange. In conjunction with a follow-up study in 1906, he demonstrated that placental structure is correlated with function and can vary dramatically between related species. Giacomini's work was highly influential in showing that placentation in lizards had converged evolutionarily on that of mammals, while establishing reptile placentology as a highly promising area for future research.


Subject(s)
Anatomy/history , Lizards/physiology , Physiology/history , Placentation , Viviparity, Nonmammalian , Animals , Female , History, 19th Century , History, 20th Century , Lizards/anatomy & histology , Pregnancy
4.
Transplant Proc ; 48(2): 395-8, 2016 Mar.
Article in English | MEDLINE | ID: mdl-27109964

ABSTRACT

BACKGROUND: Recent studies have challenged the dogma that the adult heart is a postmitotic organ and raise the possibility of the existence of resident cardiac stem cells (CSCs). Our study aimed to explore if these CSCs are present in the "ventricular tip" obtained during left ventricular assist device (LVAD) implantation from patients with end-stage heart failure (HF) and the relationship with LV dysfunctional area extent. METHODS: Four consecutive patients with ischemic cardiomyopathy and end-stage HF submitted to LVAD implantation were studied. The explanted "ventricular tip" was used as a sample of apical myocardial tissue for the pathological examination. Patients underwent clinical and echocardiographic examination, both standard transthoracic echocardiography (TTE) and speckle tracking echocardiography (STE), before LVAD implantation. RESULTS: All patients presented severe apical dysfunction, with apical akinesis/diskinesis and very low levels of apical longitudinal strain (-3.5 ± 2.9%). Despite this, the presence of CSCs was demonstrated in pathological myocardial samples of "ventricular tip" in all 4 of the patients. It was found to be a mean of 6 c-kit cells in 10 fields magnification 40×. CONCLUSIONS: Cardiac stem cells can be identified in the LV apical segment of patients who have undergone LVAD implantation despite LV apical fibrosis.


Subject(s)
Heart Failure/therapy , Heart Ventricles/cytology , Heart-Assist Devices , Myocardial Ischemia/therapy , Myocardium/cytology , Stem Cells/cytology , Biopsy , Cardiac Surgical Procedures , Echocardiography , Fibrosis , Heart Failure/diagnostic imaging , Heart Failure/pathology , Heart Ventricles/diagnostic imaging , Heart Ventricles/surgery , Humans , Myocardial Ischemia/diagnostic imaging , Myocardial Ischemia/pathology , Myocardium/pathology , Prosthesis Implantation
5.
Mol Cell Endocrinol ; 429: 41-9, 2016 07 05.
Article in English | MEDLINE | ID: mdl-27036933

ABSTRACT

Many endogenous and xenobiotic compounds are substrates and regulators of human placental ABC transporters. ABCG2 is protecting fetus against foreign chemicals. Environmental xenoestrogens, like bisphenol A (BPA) and p-nonylphenol (p-NP), mimic natural estrogens and can affect hormonal systems. Effects of BPA, p-NP, DES (diethylstilbestrol) and estradiol (E2), on ABCG2 expression were studied using human first trimester and term placental explants. Role of estrogen receptors (ER) in the effects of chemicals was studied by ER antagonist. Term placenta expressed less ABCG2 protein. In term placentas BPA (p < 0.05), p-NP (p < 0.01) and E2 (p < 0.05) decreased the ABCG2 protein expression after 48 h exposure while after 24 h exposure, only E2 decreased the expression (p < 0.05). The chemicals did not affect ABCG2 in first trimester placentas. The ER antagonist affected differently the responses of chemicals. In conclusion, environmental xenoestrogens downregulate placental ABCG2 protein expression depending on gestational age.


Subject(s)
ATP Binding Cassette Transporter, Subfamily G, Member 2/metabolism , Benzhydryl Compounds/toxicity , Estrogens/toxicity , Phenols/toxicity , Placenta/metabolism , ATP Binding Cassette Transporter, Subfamily G, Member 2/genetics , Cells, Cultured , Chorionic Villi/drug effects , Chorionic Villi/metabolism , Diethylstilbestrol/toxicity , Down-Regulation/drug effects , Female , Humans , Placenta/drug effects , Pregnancy , Pregnancy Trimester, First/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptors, Estrogen/antagonists & inhibitors , Receptors, Estrogen/metabolism
6.
Placenta ; 35(3): 152-62, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24433846

ABSTRACT

INTRODUCTION: Macrophage migration inhibitory factor (MIF) participates in the immune response to Toxoplasma gondii, triggers ERK1/2 and prostaglandin E2 (PGE2) activation, but there is limited information on these mechanisms in human trophoblast. The present study aimed to verify the role of MIF in the ERK1/2 phosphorylation and PGE2 production, as well as its effect on the susceptibility to T. gondii in BeWo cells. METHODS: BeWo cells were treated with increasing concentrations of recombinant MIF (rMIF) and/or T. gondii-soluble tachyzoite antigen (STAg) and analyzed for ERK1/2 phosphorylation and PGE2 production by Western blotting and ELISA, respectively. Cells were also treated with increasing concentrations of rMIF, rPGE2, or ERK1/2 inhibitor and tested for T. gondii proliferation. The supernatants of cells treated with rPGE2 were assayed for cytokine production by ELISA or CBA. RESULTS: ERK1/2 phosphorylation and PGE2 production increased when the cells were treated with low MIF concentrations while the parasitism control occurred only at high MIF concentrations. STAg was unable to change ERK1/2 phosphorylation or PGE2 release. BeWo cells demonstrated increased T. gondii proliferation and reduced production of pro-inflammatory cytokines when treated with PGE2, while PD98059 diminished the parasite proliferation. DISCUSSION: The intracellular mechanisms triggered by MIF are dose-dependent in BeWo cells, and PGE2 is an important factor for the persistence of T. gondii at the maternal fetal interface. CONCLUSION: MIF was unable to control T. gondii infection in BeWo cells at low concentrations since ERK1/2 and PGE2 expression were activated, demonstrating a critical effect of these mediators favoring parasite proliferation.


Subject(s)
Dinoprostone/biosynthesis , Extracellular Signal-Regulated MAP Kinases/metabolism , Macrophage Migration-Inhibitory Factors/administration & dosage , Toxoplasma/immunology , Trophoblasts/metabolism , Antigens, Protozoan/pharmacology , Cell Line, Tumor , Dinoprostone/pharmacology , Extracellular Signal-Regulated MAP Kinases/antagonists & inhibitors , Female , Flavonoids/pharmacology , Humans , Phosphorylation , Toxoplasma/growth & development , Toxoplasmosis/immunology , Trophoblasts/parasitology
7.
Placenta ; 35 Suppl: S51-6, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24215782

ABSTRACT

Complex and dynamic networks of molecules participate in the essential interactions between maternal organism, placenta and fetus in a healthy and successful pregnancy. Macrophage migratory inhibitory factor (MIF) is one of several molecules produced at implantation sites; MIF is mostly expressed by trophoblast cells. This has led to expectations of MIF's relevance as a partner in the maternal/fetal dialog. MIF is known by its biological interactions and functional roles as an activator of innate immunity, regulating subsequent adaptive responses, which include inhibition of migration of mononuclear cells in vitro, antagonism of glucocorticoids, and regulation of expression of Toll-like receptor 4. Beyond roles in the inflammatory response, MIF can interfere with proliferative activities in different cell types, as well as with cell death pathways. This intriguing factor found at the human, porcine, ovine, bovine and rodent maternal-fetal interfaces is present in a time- and spatially-dependent manner, indicating regulatory roles in the process of embryo implantation, placental development, maintenance of pregnancy and birth. Here, we will review MIF participation in placental physiology, including new evidence for a dialog with uterine cells, and a potential role in protection of uterine decidual cells.


Subject(s)
Macrophage Migration-Inhibitory Factors/physiology , Maternal-Fetal Exchange , Placenta/metabolism , Pregnancy/physiology , Animals , Cell Survival , Chorioamnionitis/metabolism , Female , Genitalia, Female/metabolism , Humans , Signal Transduction
8.
Toxicol In Vitro ; 27(3): 995-1000, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23337911

ABSTRACT

The identification of reproductive toxicants is a major scientific challenge for human health. We investigated the effects of a selected group of environmental polluting chemicals mostly provided with estrogenic activity on the human trophoblast cell lines BeWo and HTR-8/SVneo. Cells were exposed for 24h to various concentrations (from 0.1 pM to 1 mM) of atrazine (ATR), diethylstilbestrol (DES), para-nonylphenol (p-NP), resveratrol (RES) and 17 ß-estradiol (E2) and assayed for cell viability and human beta-Chorionic Gonadotropin (ß-hCG) secretion. Decrease of cell viability as respect to control, vehicle-treated, cultures was obtained for all chemicals in the concentration range of 1 µM-1 mM in both cell types. A parallel decrease of ß-hCG secretion was observed in BeWo cells, at 1 µM-1 mM concentrations, with the only exception of ATR which caused an increase at concentrations up to 1mM. ß-hCG release was also unexpectedly inhibited by ATR, DES, p-NP and RES at non-toxic (pM-nM) concentrations. These findings raise concern about the negative, potential effects of various environmental polluting chemicals on pregnancy success and fetal health.


Subject(s)
Environmental Pollutants/toxicity , Estradiol/toxicity , Estrogens/toxicity , Trophoblasts/drug effects , Atrazine/toxicity , Cell Line , Cell Survival/drug effects , Chorionic Gonadotropin/metabolism , Diethylstilbestrol/toxicity , Humans , Phenols/toxicity , Resveratrol , Stilbenes/toxicity , Trophoblasts/metabolism
9.
Placenta ; 33(3): 157-63, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22200576

ABSTRACT

Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine involved in several aspects of the immune response. MIF appears to play important roles in materno-fetal immuno-tolerance during placental establishment, modulation and growth as studied in epitheliochorial porcine and hemochorial human and mouse placentae. Here we studied the bovine placenta being multiplex, villous and synepitheliochorial with a low degree of invasion, to see if MIF could be involved. Placental tissues sampled from 12 cows at 9 stages of gestation (days 18-250), and endometrial tissues from two non-pregnant animals were processed for immunohistochemistry. Bovine MIF was detected by Western blot using anti-human MIF monoclonal antibodies. An immunoreactive band of approximately 12kDa confirmed similarities between bovine and human MIFs. Compared to the non-pregnant stage with very faint staining, the caruncular epithelium during pregnancy showed stronger staining for MIF. The intercaruncular epithelium in non-pregnant endometrium showed some reaction apically with increasing intensity at uterine gland openings; in contrast, at day 18 of gestation this staining was markedly increased. During gestation both caruncular and trophoblast epithelium of the placentomes were positive with different intensity in relation to the gestational stage. In the uterine glands, some strongly stained cells were present. The mature binucleated trophoblast giant cells were negative throughout pregnancy. During reestablishment of vascularisation, the vasculature in the caruncular area showed MIF reactivity. While supporting involvement of MIF in different placental types, the spatio-temporal variation in the bovine placenta suggests a regulatory role for MIF mainly in the interhemal barrier and during vascular development.


Subject(s)
Cattle/metabolism , Macrophage Migration-Inhibitory Factors/metabolism , Pregnancy, Animal , Pregnancy/metabolism , Animals , Endometrium/blood supply , Endometrium/metabolism , Extraembryonic Membranes/blood supply , Extraembryonic Membranes/metabolism , Female , Gestational Age , Immunohistochemistry , Macrophage Migration-Inhibitory Factors/immunology , Models, Biological , Placenta/blood supply , Placenta/metabolism , Pregnancy, Animal/metabolism
10.
Tissue Cell ; 43(1): 1-7, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21094964

ABSTRACT

The female reproductive system of the tsetse fly Glossina morsitans morsitans is analysed by scanning electron microscopy (SEM). The study focuses in particular on the choriothete, a peculiar uterine structure involved in the viviparous mode of reproduction of Glossina morsitans morsitans. Under light microscopy, the choriothete appears formed by numerous tongue-like folds projecting towards the uterine lumen and lined by a thin cuticle. SEM analysis highlights for the first time a distinctive new feature that is not visible by traditional histological methods. That is a cuticular covering of the choriothete, which shows numerous thorns in the form of crest-like structures arranged in nearly parallel lines. The role of the choriothete in pregnancy and in larval nourishment is discussed.


Subject(s)
Genitalia, Female/ultrastructure , Tsetse Flies/ultrastructure , Viviparity, Nonmammalian/physiology , Animals , Female , Genitalia, Female/cytology , Larva/cytology , Larva/ultrastructure , Tsetse Flies/cytology
12.
Placenta ; 31(10): 919-27, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20800894

ABSTRACT

Preeclampsia (PE) is a serious disorder of human pregnancy, it is often associated with fetal growth restriction (FGR) which is a failure of the fetus to reach its own growth potential. Activator protein-1 (AP-1) is a family of transcription factors inducible in response to a variety of extracellular stimuli and functions. AP-1 plays a complex role in the regulation of different fundamental cellular processes, including cell proliferation, survival, death and transformation. We investigate the expression pattern of AP-1 transcription factors in normal placentas during gestation and in placentas from PE without and with FGR using semiquantitative RT-PCR and immunohistochemistry techniques. The most interesting data concern the alterations of protein expression patterns of c-fos, Jun D and c-jun in normal gestation as well as in PE and PE-FGR pathologies. In addition, alterations but not significant changes are detected in mRNA expressions for these transcription factors. We strongly suggest that c-fos is implicated in regulating invasiveness mechanism of extravillous trophoblast in normal gestation as well as in PE placentas. In addition, we suggest that the opposite modulation of Jun D and c-jun in PE and PE-FGR supports the recent hypothesis that PE and PE-FGR could be considered two pathologies with different origin (maternal and placental) each of which has a different molecular pattern of expression.


Subject(s)
Fetal Growth Retardation/metabolism , Placenta/metabolism , Pre-Eclampsia/metabolism , Transcription Factor AP-1/metabolism , Adult , Female , Fetal Growth Retardation/genetics , Gene Expression Regulation, Developmental , Humans , Immunohistochemistry , In Vitro Techniques , Infant, Newborn , Pre-Eclampsia/genetics , Pregnancy , Proto-Oncogene Proteins c-fos/genetics , Proto-Oncogene Proteins c-fos/metabolism , Proto-Oncogene Proteins c-jun/genetics , Proto-Oncogene Proteins c-jun/metabolism , RNA/chemistry , RNA/genetics , Reverse Transcriptase Polymerase Chain Reaction , Statistics, Nonparametric , Transcription Factor AP-1/genetics , Young Adult
13.
Placenta ; 31(5): 423-30, 2010 May.
Article in English | MEDLINE | ID: mdl-20338636

ABSTRACT

ATP binding cassette transporter A1 (ABCA1) is a membrane transporter which performs cellular efflux of cholesterol and phospholipid. ABCA1's cholesterol transporting role in human placenta appears to be crucial for normal fetal development. Despite the critical importance of cholesterol in fetal development, expression of ABCA1 in the human placenta throughout gestation and its specific cellular localization have not been known yet. We therefore investigated ABCA1 expression in human placenta at first trimester and term by western blot and quantitative real-time PCR (qRT-PCR) analysis. Furthermore, its localization was investigated by immunohistochemistry and confocal microscopy. Expression of ABCA1 did not differ significantly between first trimester and term placenta at both protein and mRNA levels. Immunohistochemical data demonstrated that ABCA1 was widely localized in the villous and extravillous cytotrophoblast as well as in some stromal and endothelial cells. Confocal microscopy imaging data showed that ABCA1 was localized largely at the basolateral and to some extent at the apical side of first trimester villous cytotrophoblast cell membranes. Placental expression of ABCA1 throughout the gestation and its specific cellular localization indicate that this transporter may play an important role in materno-fetal cholesterol transfer.


Subject(s)
ATP-Binding Cassette Transporters/metabolism , Chorionic Villi/metabolism , Pregnancy Trimester, First , Term Birth , Trophoblasts/metabolism , ATP Binding Cassette Transporter 1 , ATP-Binding Cassette Transporters/genetics , Adult , Blotting, Western , Cholesterol/metabolism , Chorionic Villi/anatomy & histology , Female , Gene Expression , Gene Expression Regulation, Developmental , Humans , Immunohistochemistry , Maternal-Fetal Exchange , Microscopy, Confocal , Pregnancy , RNA, Messenger/metabolism , Trophoblasts/cytology
14.
Placenta ; 28(11-12): 1123-32, 2007.
Article in English | MEDLINE | ID: mdl-17664003

ABSTRACT

There is evidence that alpha-smooth muscle actin (alpha-SMA) is a protein that plays a pivotal role in the production of contractile forces and it is induced by transforming growth factor-beta1 (TGF-beta1). We have analysed the expression of alpha-SMA, TGF-beta1, its receptor RI and the activator phospho-Smad2 in (a) fetal growth restriction pre-eclamptic placentae characterised by early onset and absence of end diastolic velocities in the umbilical arteries (FGR-AED) and (b) control placentae accurately matched for gestational age. The study was performed by immunohistochemical, quantitative Western blotting, ELISA, RT-PCR and in vitro analyses. We found that TGF-beta1 stimulates alpha-SMA production in chorionic villi cultured in vitro. In addition, we observed that in vivo TGF-beta1 concentration is significantly higher in FGR-AED placental samples than in control placentae and that this growth factor could have a paracrine action on villous stroma myofibroblasts expressing TGF-beta1 receptors and phospho-Smad2. Indeed, we report that alpha-SMA undergoes a redistribution in FGR-AED placental villous tree, i.e. we show that alpha-SMA is enhanced in medium and small stem villi and significantly decreased in the peripheral villi. Our data allow us to consider TGF-beta1 and alpha-SMA as key molecules related to FGR-AED placental villous tree phenotypic changes responsible for increased impedance to blood flow observable in this pathology.


Subject(s)
Actins/metabolism , Fetal Growth Retardation/physiopathology , Placenta/physiopathology , Pre-Eclampsia/physiopathology , Pregnancy Complications , Protein Serine-Threonine Kinases/metabolism , Receptors, Transforming Growth Factor beta/metabolism , Transforming Growth Factor beta1/metabolism , Adult , Female , Fetus , Gene Expression Regulation , Humans , Placenta/blood supply , Pregnancy , Protein Serine-Threonine Kinases/genetics , RNA, Messenger/metabolism , Receptor, Transforming Growth Factor-beta Type I , Receptors, Transforming Growth Factor beta/genetics , Signal Transduction , Transforming Growth Factor beta1/genetics
15.
Placenta ; 24(5): 489-500, 2003 May.
Article in English | MEDLINE | ID: mdl-12744925

ABSTRACT

Glycosylation of the foeto-maternal interface of the skink Chalcides chalcides has been examined at various stages of gestation using lectin histochemistry. Specimens of incubatory chamber or placenta from early, mid-, late- and near-term pregnancy were fixed and embedded in epoxy resin. Areas of foeto-maternal apposition were probed with a panel of biotinylated lectins followed by an avidin-peroxidase revealing system to identify various classes of glycan at the interface. Both the external epithelium of unspecialized bilaminar omphalopleure, which forms by early pregnancy, and chorioallantoic membrane which develops by mid-pregnancy, were composed of two phenotypes, one of which secreted a wide range of glycans including high mannose and complex N-glycan, N-acetyl glucosamine, lactosamine and galactosamine, which became less prominent from mid-pregnancy onwards. The uterine epithelium also contained a well-developed secretory apparatus producing a similar range of glycans and there were indications that glycosylated secretions were taken up by the overlying chorioallantois. Foetal vasculature was well developed while maternal vessels appeared more contracted, and both were richly sialylated like their therian equivalents. Our findings indicate that this reptile has evolved a true epitheliochorial placenta with many aspects in common with its therian counterparts but also with unique features of its own.


Subject(s)
Lectins/metabolism , Lizards/physiology , Maternal-Fetal Exchange/physiology , Placenta/metabolism , Polysaccharides/metabolism , Animals , Extraembryonic Membranes/chemistry , Extraembryonic Membranes/metabolism , Female , Glycosylation , Immunoenzyme Techniques , Lectins/analysis , Placenta/chemistry , Placenta/cytology , Polysaccharides/analysis , Pregnancy
16.
Ann Rheum Dis ; 62(5): 460-4, 2003 May.
Article in English | MEDLINE | ID: mdl-12695161

ABSTRACT

OBJECTIVE: To evaluate whether, in patients with the diffuse form of systemic sclerosis (dSSc), macrophage migration inhibitory factor (MIF) production is dysregulated. METHODS: 10 patients with dSSc and 10 healthy controls, matched for age and sex, were studied. MIF expression was evaluated by immunohistochemistry on formalin fixed skin biopsies of patients with dSSc and controls. MIF levels were assayed in the sera and in the supernatants of skin cultured fibroblasts by a colorimetric sandwich enzyme linked immunosorbent assay (ELISA). MIF concentrations in culture medium samples and in serum samples were compared by Student's two tailed t test for unpaired data. RESULTS: Anti-MIF antibody immunostained the basal and mainly suprabasal keratinocytes. Small perivascular clusters of infiltrating mononuclear cells were positive; scattered spindle fibroblast-like cells were immunostained in superficial and deep dermal layers. The serum concentrations of MIF in patients with dSSc (mean (SD) 10705.6 (9311) pg/ml) were significantly higher than in controls (2157.5 (1288.6) pg/ml; p=0.011); MIF levels from dSSc fibroblast cultures (mean (SD) 1.74 (0.16) ng/2 x 10(5) cells) were also significantly higher than in controls (0.6 (0.2) ng/2 x 10(5) cells; p=0.008). CONCLUSION: These results suggest that MIF may be involved in the amplifying proinflammatory loop leading to scleroderma tissue remodelling.


Subject(s)
Macrophage Migration-Inhibitory Factors/analysis , Scleroderma, Systemic/metabolism , Adult , Aged , Biopsy , Cells, Cultured/metabolism , Enzyme-Linked Immunosorbent Assay/methods , Female , Fibroblasts/metabolism , Humans , Immunohistochemistry/methods , Macrophage Migration-Inhibitory Factors/blood , Middle Aged , Up-Regulation
17.
Eur J Gynaecol Oncol ; 23(2): 145-50, 2002.
Article in English | MEDLINE | ID: mdl-12013113

ABSTRACT

PURPOSE OF INVESTIGATION: In this study we analyzed the immunohistochemical expression of specific types of interferon (IFN) in human papillomavirus (HPV) associated cervical lesions. METHODS: Reactivity to anti-IFN-alpha,-beta and -gamma and to anti-IFN-alpha/beta- and gamma-receptors was tested in 33 cervical punch biopsies from 24 HPV-infected women and nine healthy controls. The HPV-infected cases were subdivided into low-risk and high-risk groups, according to the known "oncogenic" potential of the HPV-types detected by PCR. RESULTS: Cervical epithelium and stroma in HPV-negative as well as low-risk HPV-positive samples were diffusely stained by anti IFN-alpha, beta and gamma antibodies. In contrast, a significantly lower percentage of high-risk HPV-infected tissues was immunoreactive to IFN-beta in the stroma and IFN-gamma in the epithelium. There were no relevant differences between control and HPV cases in the expression of IFN-receptors. CONCLUSION: We show that a decreased production of some specific classes of IFN is associated with high-risk-type HPV lesions suggesting an important role of IFN distribution patterns in the pathogenesis of HPV lesions.


Subject(s)
Interferons/analysis , Papillomaviridae/isolation & purification , Papillomavirus Infections/immunology , Receptors, Interferon/analysis , Tumor Virus Infections/immunology , Uterine Cervical Dysplasia/immunology , Uterine Cervical Neoplasms/immunology , Adult , Biopsy, Needle , Female , Humans , Immunohistochemistry , Interferon-alpha/analysis , Interferon-beta/analysis , Interferon-gamma/analysis , Polymerase Chain Reaction , Uterine Cervical Neoplasms/metabolism , Uterine Cervical Neoplasms/virology , Uterine Cervical Dysplasia/metabolism , Uterine Cervical Dysplasia/virology
18.
Am J Reprod Immunol ; 48(6): 404-9, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12607777

ABSTRACT

PROBLEM: Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine involved in reproduction. Presently there is no information on the possible involvement of MIF in the onset of labor. METHODS: Macrophage migration inhibitory factor was assayed, by enzyme-linked immunosorbent assay (ELISA), in maternal serum (MS) and amniotic fluid (AF) both, at midtrimester and at term, as well as in cord serum (CS) at birth. Extraembryonic membranes were analyzed by immunohistochemistry. RESULTS: Amniotic fluid MIF concentrations were significantly higher at term (median 62.10 ng/mL) than at midtrimester (median 20.07 ng/mL) and reached a peak in term labor (median 258.80 ng/mL). The AF/MS ratio varied from a median of 4.34 at midtrimester and 33.7 at term labor. The MS/CS ratio was 0.4. Migration inhibitory factor immunoreactivity was found in different cell layers of the extraembryonic membranes. CONCLUSIONS: The increased secretion of MIF in AF at term, particularly at term labor, suggests that MIF contributes to the inflammatory events leading to labor.


Subject(s)
Amniotic Fluid/chemistry , Labor, Obstetric/blood , Macrophage Migration-Inhibitory Factors/analysis , Pregnancy/blood , Adult , Amniocentesis , Chorion/chemistry , Decidua/chemistry , Enzyme-Linked Immunosorbent Assay , Female , Fetal Blood/chemistry , Humans , Infant, Newborn , Macrophage Migration-Inhibitory Factors/blood , Macrophage Migration-Inhibitory Factors/physiology , Pregnancy Trimester, Second , Pregnancy Trimester, Third
19.
Placenta ; 22(8-9): 735-41, 2001.
Article in English | MEDLINE | ID: mdl-11597194

ABSTRACT

The H beta 58 gene, whose disruption in mice causes reabsorption of the embryo at 9.5 days post-conception, is believed to be essential for development of the placenta. Although the H beta 58 gene is well conserved in some Amniota, nothing is known about its presence in reptiles, some species of which have developed a chorioallantoic placenta. In this work, we investigated the expression of H beta 58 mRNA and protein in the three-toed skink, Chalcides chalcides. H beta 58 protein expression was found in the uterine epithelium beginning from the peri-ovulatory stage. However, it increased strongly at the moment of placental formation, when a high level of expression of mRNA and protein was also observed in the extra-embryonic membranes. The expression of H beta 58 mRNA and protein was maintained, although to a lesser degree, in the placenta during late pregnancy. It was also present in the early embryo. Finally, cloning and sequencing of a gene fragment revealed strong homology of the reptile gene with that of mammals. The high degree of conservation of the gene in amniote vertebrates and its presence in a viviparous squamate reptile (as in mammals) indicates an important role of this gene in the chorioallantoic placenta formation and development.


Subject(s)
Carrier Proteins/genetics , Placenta/physiology , Reptiles/genetics , Reptilian Proteins/genetics , Vesicular Transport Proteins , Allantois/chemistry , Animals , Base Sequence , Carrier Proteins/analysis , Chorion/chemistry , Cloning, Molecular , Epithelium/chemistry , Female , Gene Expression , Molecular Sequence Data , Ovulation , Pregnancy , RNA, Messenger/analysis , Rats , Reptilian Proteins/analysis , Reverse Transcriptase Polymerase Chain Reaction , Sequence Analysis, DNA , Sequence Homology , Uterus/chemistry
20.
Biol Reprod ; 64(4): 1200-5, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11259268

ABSTRACT

Macrophage migration inhibitory factor (MIF) was discovered as an activated T-lymphocyte-derived protein that inhibits the random migration of macrophages in vitro. Subsequently, knowledge of the physiological actions of MIF was extended to include its role as a proinflammatory cytokine that affects several functions of macrophages and lymphocytes. Previous reports have suggested an involvement of MIF in reproduction. However, no data are currently available on the presence of this cytokine in the human endometrium. In this study, the expression and tissue localization of MIF was evaluated in specimens of cycling endometrium, first trimester placenta bed biopsy, and isolated endometrial glands by Western blot analysis, immunohistochemistry, ELISA, and reverse transcription-polymerase chain reaction. The results demonstrated that MIF is expressed in human endometrium across the menstrual cycle and in early pregnancy. Immunohistochemical localization identified the protein in glandular epithelium, in stromal and predecidualized stromal cells of cycling endometrium, as well as in the decidua of first-trimester placenta. The proinflammatory features and specific actions of MIF on lymphoid cells suggest its potential involvement in several aspects of endometrial physiology.


Subject(s)
Endometrium/chemistry , Gene Expression , Macrophage Migration-Inhibitory Factors/analysis , Macrophage Migration-Inhibitory Factors/genetics , Menstrual Cycle , Blotting, Western , Deoxyribonucleases, Type II Site-Specific , Endometrium/metabolism , Female , Humans , Immunohistochemistry , Pregnancy , RNA, Messenger/analysis , Reverse Transcriptase Polymerase Chain Reaction , Tissue Distribution
SELECTION OF CITATIONS
SEARCH DETAIL
...